Medical Supplies and Services News

 ●The funding includes investments commitments from key shareholders of the Company, including the Company’s CEO Alexander Rabinovich, as well as leading pharma-focused hedge funds, including Bennu...

Melbourne, Australia, June 22, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX | OTCQB:INNMF), (“Amplia” or the “Company”) provides a letter to shareholders from CEO and Managing...

DENVER, June 22, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients...

Phase 1/2 SSc study is expected to enroll patients at over 20 participating clinical sites in at least five countries Recently completed Phase 1 Single Ascending Dose study of PRO-203 in healthy...

伊斯坦布尔, June 20, 2026 (GLOBE NEWSWIRE) -- European Academy of Allergy and Clinical Immunology (EAACI) 2026 年年会于伊斯坦布尔顺利闭幕。本次大会以“零负担愿景：无过敏、无哮喘病痛的未来”为主题，来自 110 个国家和地区的 7429 名代表参会。 ...

伊斯坦堡, June 20, 2026 (GLOBE NEWSWIRE) -- European Academy of Allergy and Clinical Immunology (歐洲過敏症及臨床免疫學學會，簡稱 EAACI) 2026 年年度大會已在伊斯坦堡圓滿謝幕，是次盛會以實現「『零願景』的未來，消除過敏症與哮喘病帶來的健康負擔」為題，匯聚了 110 個國家共 7,429...

ISTANBUL, 19 juin 2026 (GLOBE NEWSWIRE) -- L’European Academy of Allergy and Clinical Immunology (EAACI) a clôturé avec succès l’édition 2026 de son Congrès annuel à Istanbul, qui a réuni 7 429...

ISTANBUL, June 19, 2026 (GLOBE NEWSWIRE) -- Die European Academy of Allergy and Clinical Immunology (EAACI) hat ihren Jahreskongress 2026 in Istanbul erfolgreich abgeschlossen. Unter dem Motto...

איסטנבול, June 19, 2026 (GLOBE NEWSWIRE) -- האקדמיה האירופית לאלרגיה ואימונולוגיה קלינית (EAACI) סיימה בהצלחה את הקונגרס השנתי שלה לשנת 2026 באיסטנבול, בה השתתפו 7,429 נציגים מ-110 מדינות תחת...

ISTANBUL, June 20, 2026 (GLOBE NEWSWIRE) -- European Academy of Allergy and Clinical Immunology (EAACI) telah sukses menyelenggarakan Kongres Tahunan 2026 di Istanbul. Acara ini menghadirkan 7.429...